Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

16.07 +0.18 (+1.13%)

Streaming Delayed Price Updated: 2:33 PM EST, Nov 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	101,425
Open	15.99
Bid (Size)	16.06 (100)
Ask (Size)	16.08 (600)
Prev. Close	15.89
Today's Range	15.93 - 16.11
52wk Range	10.45 - 20.71
Shares Outstanding	354,200,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Cash-Burning Stocks We Approach with Caution

November 23, 2025

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

Via StockStory

Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Performance

YTD	-10.7%	-10.7%
1 Month	+4.6%	+4.6%
3 Month	+11.3%	+11.3%
6 Month	+36.2%	+36.2%
1 Year	-18.3%	-18.3%

More News

Bausch + Lomb to Participate in Citi Global Healthcare Conference

November 18, 2025

From Bausch + Lomb Corporation

Via Business Wire

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

November 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

November 11, 2025

Via StockStory

Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program

November 10, 2025

From Bausch + Lomb Corporation

Via Business Wire

Medical Devices & Supplies - Specialty Stocks Q3 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers

November 10, 2025

Via StockStory

5 Revealing Analyst Questions From Bausch + Lomb’s Q3 Earnings Call

November 05, 2025

Via StockStory

Bausch + Lomb to Hold Investor Day on Nov. 13

November 03, 2025

From Bausch + Lomb Corporation

Via Business Wire

BLCO Q3 Deep Dive: Pharmaceuticals and Pipeline Drive Growth, Margin Initiatives Take Shape

October 30, 2025

Via StockStory

Bausch + Lomb Corp (NYSE:BLCO) Q3 2025 Earnings: EPS Beat and Reaffirmed Guidance Drive Shares Higher ↗

October 29, 2025

Via Chartmill

Bausch + Lomb (NYSE:BLCO) Reports Q3 In Line With Expectations, Stock Soars

October 29, 2025

Via StockStory

Bausch + Lomb Announces Third-Quarter 2025 Results

October 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) To Report Earnings Tomorrow: Here Is What To Expect

October 27, 2025

Via StockStory

Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know

October 20, 2025

Via StockStory

Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report ↗

October 19, 2025

Via Stocktwits

3 Stocks Under $50 We Steer Clear Of

October 17, 2025

Via StockStory

3 Unpopular Stocks Walking a Fine Line

October 03, 2025

Via StockStory

Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13

September 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm

September 26, 2025

Via StockStory

Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know

September 25, 2025

Via StockStory

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

September 11, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

September 09, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why

September 08, 2025

Via StockStory

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?

Yes, Bausch + Lomb Corporation Common Shares is publicly traded.

What exchange does Bausch + Lomb Corporation Common Shares trade on?

Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange

What is the ticker symbol for Bausch + Lomb Corporation Common Shares?

The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange

What is the current price of Bausch + Lomb Corporation Common Shares?

The current price of Bausch + Lomb Corporation Common Shares is 16.07

When was Bausch + Lomb Corporation Common Shares last traded?

The last trade of Bausch + Lomb Corporation Common Shares was at 11/26/25 02:33 PM ET

What is the market capitalization of Bausch + Lomb Corporation Common Shares?

The market capitalization of Bausch + Lomb Corporation Common Shares is 5.69B

How many shares of Bausch + Lomb Corporation Common Shares are outstanding?

Bausch + Lomb Corporation Common Shares has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.